MODTX fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Modus Therapeutics Holding AB operates as a biotechnology company. It develops sevuparin with a focus on diseases with a high unmet medical need. The firm focuses to develop sevuparin for patients with sepsis / septic shock, which is a serious and often fatal condition. The company was founded in 2011 and is headquartered in Stockholm, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
MODTX does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company